Rifapentine and Isoniazid for Latent Tuberculosis

被引：0
|
作者：
Mirsaeidi, Mehdi [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60607 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1447 / 1448
页数：2
相关论文
共 50 条
  • [1] Rifapentine and Isoniazid for Latent Tuberculosis REPLY
    Sterling, Timothy R.
    Moro, Ruth
    Villarino, M. Elsa
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1448 - 1448
  • [2] Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Sterling, Timothy R.
    Villarino, M. Elsa
    Borisov, Andrey S.
    Shang, Nong
    Gordin, Fred
    Bliven-Sizemore, Erin
    Hackman, Judith
    Hamilton, Carol Dukes
    Menzies, Dick
    Kerrigan, Amy
    Weis, Stephen E.
    Weiner, Marc
    Wing, Diane
    Conde, Marcus B.
    Bozeman, Lorna
    Horsburgh, C. Robert, Jr.
    Chaisson, Richard E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2155 - 2166
  • [3] Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection
    Phaisal, Weeraya
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Tawan, Monta
    Puthanakit, Thanyawee
    Wittayalertpanya, Supeecha
    Chariyavilaskul, Pajaree
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 725 - 732
  • [4] Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice
    Froberg, Gabrielle
    Jansson, Lena
    Bruchfeld, Judith
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (02)
  • [5] Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection
    Weiner, Marc
    Savic, Radojka M.
    Mac Kenzie, Awilliam R.
    Wing, Diane
    Peloquin, Charles A.
    Engle, Melissa
    Bliven, Erin
    Prihoda, Thomas J.
    Gelfond, Jonathan A. L.
    Scott, Nigel A.
    Abdel-Rahman, Susan M.
    Kearns, Gregory L.
    Burman, William J.
    Sterling, Timothy R.
    Villarino, M. Elsa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (02) : 132 - 145
  • [6] Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
    Ilaiwy, Ghassan
    Dowdy, David W.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2021, 24
  • [7] COMBINED USE OF ISONIAZID AND RIFAPENTINE IN THE TREATMENT OF LATENT TUBERCULOSIS: A BUDGET IMPACT ANALYSIS
    Sena, R. R.
    Wichmann, R. M.
    Silva, M. T.
    VALUE IN HEALTH, 2017, 20 (09) : A928 - A928
  • [8] Rifapentine plus isoniazid for latent tuberculosis infection in Brazil: a retrospective cohort study
    Chaves, Beatriz
    Souza, Ana Carolina
    Leung, Janaina
    Costa, Walter
    Santos, Ana Paula
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [9] Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts
    Schechter, M
    Zajdenverg, R
    Falco, G
    Barnes, GL
    Faulhaber, JC
    Coberly, JS
    Moore, RD
    Chaisson, RE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (08) : 922 - 926
  • [10] Short-course isoniazid plus rifapentine therapy for latent tuberculosis in Brazil
    Croda, Julio
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2015, 48 (05) : 505 - 506
12345